SynthesisYonsei medical journal2022

The Clinical Efficacy of Type 2 Inflammation-Specific Agents Targeting Interleukins in Reducing Exacerbations in Severe Asthma: A Meta-Analysis.

Jonghoo Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.